- Q1 2024 Cytek Biosciences Inc Earnings Call TranscriptMay 08, 2024$6.27 (-1.72%)Earnings
- Q4 2023 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2024$8.74 (-1.24%)Earnings
- Cytek Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Cytek Biosciences Inc Earnings Call TranscriptNov 07, 2023$4.45 (+2.06%)Earnings
- Cytek Biosciences Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Cytek Biosciences Inc Earnings Call TranscriptAug 08, 2023$8.92 (-2.73%)Earnings
- Cytek Biosciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Cytek Biosciences Inc Earnings Call TranscriptMay 09, 2023$11.67 (+0.60%)Earnings
- Q4 2022 Cytek Biosciences Inc Earnings Call TranscriptFeb 28, 2023$10.3 (-2.28%)Earnings
- Cytek Biosciences Inc To Acquire Flow Cytometry and Imaging Business From DiaSorin- M&A Call TranscriptFeb 13, 2023
- Cytek Biosciences Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Cytek Biosciences Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Cytek Biosciences Inc Earnings Call TranscriptNov 09, 2022$13.7 (-5.65%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Cytek Biosciences Inc Earnings Call TranscriptAug 10, 2022$15.45 (+5.17%)Earnings
- Cytek Biosciences Inc Corporate Analyst Meeting TranscriptJun 22, 2022
- Q1 2022 Cytek Biosciences Inc Earnings Call TranscriptMay 11, 2022$7.41 (-7.84%)Earnings
- Q4 2021 Cytek Biosciences Inc Earnings Call TranscriptFeb 23, 2022$13.12 (-2.53%)Earnings
- Q3 2021 Cytek Biosciences Inc Earnings Call TranscriptNov 08, 2021$25.04 (+1.34%)Earnings
- Cytek Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
Cytek Biosciences Inc at Credit Suisse Healthcare Conference Transcript
Great. Thank you. And actually, thanks to Credit Suisse for giving us an opportunity to present to the audience here about Cytek. I'm Wenbin Jiang, CEO of the company; then Patrick, our CFO, over there.
Okay, perfect. Okay. As usual, the safe harbor statement, I don't expect you want me to read through. So I'm going to flip over. This is completely Cytek's leadership team, and many of them are already there for years. But I want to, in particular, introduce you Todd Garland, our Chief Commercial Officer joining us 6 months ago who has been leading Cytek's commercial activities, especially for our international sales. That's what he has been focusing on within the last 6 months. And Chris Williams just joined us a week ago from Thermo Fisher.
So to quickly go through a summary of where we are regarding to the company. As you can see, first years, we have a technology that has really been already validated by the number of instruments already placed actually through the end of Q3. We just announced our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)